S&P 500   4,592.13 (+1.31%)
DOW   35,407.24 (+1.08%)
QQQ   371.96 (+1.50%)
AAPL   168.87 (+1.59%)
MSFT   309.69 (+2.10%)
FB   323.99 (+1.38%)
GOOGL   2,736.00 (+1.25%)
AMZN   3,126.58 (+0.02%)
TSLA   1,032.72 (+3.72%)
NVDA   252.74 (+0.83%)
BABA   133.58 (+4.57%)
NIO   30.42 (+6.25%)
AMD   127.48 (-0.62%)
CGC   7.95 (+4.06%)
MU   89.34 (-0.73%)
GE   101.01 (+0.39%)
T   27.33 (+0.18%)
F   22.36 (-0.40%)
DIS   151.17 (+0.71%)
AMC   19.54 (+6.66%)
PFE   54.00 (+0.86%)
ACB   5.00 (+2.88%)
BA   219.96 (+1.33%)
S&P 500   4,592.13 (+1.31%)
DOW   35,407.24 (+1.08%)
QQQ   371.96 (+1.50%)
AAPL   168.87 (+1.59%)
MSFT   309.69 (+2.10%)
FB   323.99 (+1.38%)
GOOGL   2,736.00 (+1.25%)
AMZN   3,126.58 (+0.02%)
TSLA   1,032.72 (+3.72%)
NVDA   252.74 (+0.83%)
BABA   133.58 (+4.57%)
NIO   30.42 (+6.25%)
AMD   127.48 (-0.62%)
CGC   7.95 (+4.06%)
MU   89.34 (-0.73%)
GE   101.01 (+0.39%)
T   27.33 (+0.18%)
F   22.36 (-0.40%)
DIS   151.17 (+0.71%)
AMC   19.54 (+6.66%)
PFE   54.00 (+0.86%)
ACB   5.00 (+2.88%)
BA   219.96 (+1.33%)
S&P 500   4,592.13 (+1.31%)
DOW   35,407.24 (+1.08%)
QQQ   371.96 (+1.50%)
AAPL   168.87 (+1.59%)
MSFT   309.69 (+2.10%)
FB   323.99 (+1.38%)
GOOGL   2,736.00 (+1.25%)
AMZN   3,126.58 (+0.02%)
TSLA   1,032.72 (+3.72%)
NVDA   252.74 (+0.83%)
BABA   133.58 (+4.57%)
NIO   30.42 (+6.25%)
AMD   127.48 (-0.62%)
CGC   7.95 (+4.06%)
MU   89.34 (-0.73%)
GE   101.01 (+0.39%)
T   27.33 (+0.18%)
F   22.36 (-0.40%)
DIS   151.17 (+0.71%)
AMC   19.54 (+6.66%)
PFE   54.00 (+0.86%)
ACB   5.00 (+2.88%)
BA   219.96 (+1.33%)
S&P 500   4,592.13 (+1.31%)
DOW   35,407.24 (+1.08%)
QQQ   371.96 (+1.50%)
AAPL   168.87 (+1.59%)
MSFT   309.69 (+2.10%)
FB   323.99 (+1.38%)
GOOGL   2,736.00 (+1.25%)
AMZN   3,126.58 (+0.02%)
TSLA   1,032.72 (+3.72%)
NVDA   252.74 (+0.83%)
BABA   133.58 (+4.57%)
NIO   30.42 (+6.25%)
AMD   127.48 (-0.62%)
CGC   7.95 (+4.06%)
MU   89.34 (-0.73%)
GE   101.01 (+0.39%)
T   27.33 (+0.18%)
F   22.36 (-0.40%)
DIS   151.17 (+0.71%)
AMC   19.54 (+6.66%)
PFE   54.00 (+0.86%)
ACB   5.00 (+2.88%)
BA   219.96 (+1.33%)
NYSE:ITGR

Integer Stock Forecast, Price & News

$82.79
+1.94 (+2.40%)
(As of 01/20/2022 12:27 PM ET)
Add
Compare
Today's Range
$80.98
$83.23
50-Day Range
$79.74
$89.73
52-Week Range
$73.32
$101.61
Volume
1,038 shs
Average Volume
151,044 shs
Market Capitalization
$2.73 billion
P/E Ratio
31.01
Dividend Yield
N/A
Beta
1.37
30 days | 90 days | 365 days | Advanced Chart
Receive ITGR News and Ratings via Email

Sign-up to receive the latest news and ratings for Integer and its competitors with MarketBeat's FREE daily newsletter.


Integer logo

About Integer

Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Miscellaneous electrical machinery, equipment, & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
Previous Symbol
NASDAQ:ITGR
CUSIP
39153L10
Employees
7,500
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.07 billion
Cash Flow
$5.43 per share
Book Value
$38.66 per share

Profitability

Net Income
$77.26 million
Pretax Margin
8.24%

Debt

Price-To-Earnings

Miscellaneous

Free Float
32,332,000
Market Cap
$2.73 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/28/2021
Today
1/20/2022
Next Earnings (Estimated)
2/17/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.43 out of 5 stars

Medical Sector

174th out of 1,415 stocks

Miscellaneous Electrical Machinery, Equipment, & Supplies Industry

5th out of 31 stocks

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -












Integer (NYSE:ITGR) Frequently Asked Questions

Is Integer a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Integer stock.
View analyst ratings for Integer
or view top-rated stocks.

How has Integer's stock been impacted by Coronavirus?

Integer's stock was trading at $79.33 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ITGR stock has increased by 4.4% and is now trading at $82.79.
View which stocks have been most impacted by COVID-19
.

When is Integer's next earnings date?

Integer is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for Integer
.

How were Integer's earnings last quarter?

Integer Holdings Co. (NYSE:ITGR) released its quarterly earnings data on Thursday, October, 28th. The medical equipment provider reported $1.05 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.09. The medical equipment provider earned $305.57 million during the quarter, compared to analyst estimates of $303.23 million. Integer had a net margin of 7.51% and a trailing twelve-month return on equity of 9.69%. The firm's quarterly revenue was up 29.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.50 EPS.
View Integer's earnings history
.

What guidance has Integer issued on next quarter's earnings?

Integer updated its FY 2021 earnings guidance on Thursday, November, 4th. The company provided EPS guidance of $3.900-$4.150 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.880. The company issued revenue guidance of $1.21 billion-$1.22 billion, compared to the consensus revenue estimate of $1.21 billion.

What price target have analysts set for ITGR?

2 Wall Street analysts have issued 1 year price targets for Integer's shares. Their forecasts range from $105.00 to $111.00. On average, they expect Integer's share price to reach $108.00 in the next year. This suggests a possible upside of 30.5% from the stock's current price.
View analysts' price targets for Integer
or view top-rated stocks among Wall Street analysts.

Who are Integer's key executives?

Integer's management team includes the following people:
  • Joseph William Dziedzic, President, Chief Executive Officer & Director
  • Jennifer M. Bolt, Senior Vice President-Global Operations & ESG
  • Jason K. Garland, Chief Financial Officer & Executive Vice President
  • Elizabeth K. Giddens, Secretary, Chief Ethics & Compliance Officer
  • Kirk Thor, Chief Human Resources Officer & Executive VP

What is Joseph Dziedzic's approval rating as Integer's CEO?

40 employees have rated Integer CEO Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among Integer's employees.

What other stocks do shareholders of Integer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

What is Integer's stock symbol?

Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."

Who are Integer's major shareholders?

Integer's stock is owned by many different retail and institutional investors. Top institutional shareholders include Tributary Capital Management LLC (0.59%), Scout Investments Inc. (0.34%), State of Alaska Department of Revenue (0.07%) and Crossmark Global Holdings Inc. (0.01%). Company insiders that own Integer stock include Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic and Pamela G Bailey.
View institutional ownership trends for Integer
.

Which major investors are selling Integer stock?

ITGR stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., and State of Alaska Department of Revenue. Company insiders that have sold Integer company stock in the last year include Anthony W Borowicz, Bill R Sanford, Carter Houghton, Jean M Hobby, Joseph F Flanagan, and Pamela G Bailey.
View insider buying and selling activity for Integer
or view top insider-selling stocks.

Which major investors are buying Integer stock?

ITGR stock was bought by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC, and Crossmark Global Holdings Inc..
View insider buying and selling activity for Integer
or or view top insider-buying stocks.

How do I buy shares of Integer?

Shares of ITGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Integer's stock price today?

One share of ITGR stock can currently be purchased for approximately $82.79.

How much money does Integer make?

Integer has a market capitalization of $2.73 billion and generates $1.07 billion in revenue each year. The medical equipment provider earns $77.26 million in net income (profit) each year or $2.67 on an earnings per share basis.

How many employees does Integer have?

Integer employs 7,500 workers across the globe.

What is Integer's official website?

The official website for Integer is www.integer.net.

Where are Integer's headquarters?

How can I contact Integer?

Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The medical equipment provider can be reached via phone at (214) 618-5243, via email at [email protected], or via fax at 716-759-5654.


This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.